Publication | Open Access

Circulating procoagulant microparticles and soluble GPV in myocardial infarction treated by primary percutaneous transluminal coronary angioplasty. A possible role for GPIIb‐IIIa antagonists

Percutaneous Coronary InterventionThrombosisCardiovascular DiseaseMedicineVascular BiologyPharmacotherapySoluble GpvPlatelet AntagonistPharmacologyGpiib‐iiia AntagonistsCardiologyCoronary Artery DiseaseAcute Myocardial InfarctionMyocardial Infarction